OCEL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 kov. 2024 @ 22:14):
Our systems believe the stock currently is undervalued by 0.24% compare to its pairs and should correct upwards.

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases...

Stats
Dzisiejszy wolumen	4 735
Średni wolumen	4 716
Kapitalizacja rynkowa	19.97M
EPS	$-0.150 ( Q4 \| 2024-01-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.567 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACUT 16.78%

AIMD -3.89%

AKABY 0.00%

AOBI 0.00%

ARNI 417.24%

BETRF 0.00%

BRAXF 7.14%

BVNRY -7.81%

CLVLY -2.39%

COEP 1.05%

CPMV 0.00%

CRXM 0.00%

CSLLY 0.20%

ERGO 0.00%

GSTC 0.00%

IPCIF 0.00%

LVCLY 0.00%

MLCT 2.63%

NPTX 0.00%

NUGX 0.00%

OBMP -37.10%

OCEL -0.27%

ODTC 0.00%

OTLC 6.45%

PFND 0.00%

PROT 0.00%

PVCT 1.11%

QSAM -99.95%

RGBP 10.45%

RGBPP 0.00%

RSPI 8.11%

SIGY 0.00%

SILO 1.01%

SKYE 10.33%

SNNAQ 0.00%

SPHRY 0.00%

UCBJY 0.39%

USRM 0.00%

VGLS 100.00%

VICP 59.29%

WXXWY -1.02%

Insider Trading

Date	Person	Action	Amount	type
2023-06-29	Leider Harry L.	Buy	500 000	Common Stock
2023-06-28	Leider Harry L.	Buy	549 450	Common Stock
2023-12-19	Leider Harry L.	Sell	5 248	Common Stock
2023-07-07	Skycrest Holdings, Llc	Buy	320 710	Common Stock
2023-06-29	Skycrest Holdings, Llc	Buy	200 000	Common Stock

INSIDER POWER
-81.72
Last 93 transactions
Buy: 116 969 610 \| Sell: 385 387 546

Korelacja (AI algo v.1.1b): Undervalued: 0.24% $2.76 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Organicell Regenerative Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Organicell Regenerative Finanse

Annual	2023
Przychody:	$4.56M
Zysk brutto:	$4.05M (88.86 %)
EPS:	$-0.990

FY	2023
Przychody:	$4.56M
Zysk brutto:	$4.05M (88.86 %)
EPS:	$-0.990

FY	2022
Przychody:	$6.49M
Zysk brutto:	$5.74M (88.39 %)
EPS:	$-1.570

FY	2021
Przychody:	$5.60M
Zysk brutto:	$5.05M (90.21 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

Organicell Regenerative Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Organicell Regenerative

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.